-
August 01, 2012
" BP plc (ADR) (NYSE:BP) posted second quarter earnings per share of $1.16, missing the Zacks Consensus Estimate ...
-
July 31, 2012
Pfizer Inc. (PFE) posted second quarter earnings of 62 cents per share, well above the Zacks Consensus Estimate of ...
-
July 31, 2012
All eyes are on the U.S. Federal Reserve and the European Central Bank, as the two critical central banks hold their ...
-
July 31, 2012
Tuesday, July 31, 2012 All eyes are on the U.S. Federal Reserve and the European Central Bank as the two critical ...
-
July 31, 2012
Pfizer (NYSE:PFE) announced its results for the most recent quarter on July 31, 2012. Pfizer is a global ...
-
July 30, 2012
Huntington, fresh off its initial foray into the ETF industry in June, has doubled the size of its lineup with the ...
-
July 27, 2012
MoneyShow's Tom Aspray takes an in-depth look at his successful Charts in Play Portfolio, as he looks to take ...
-
July 27, 2012
Amgen (AMGN) continued its strong performance in 2012 with second quarter earnings coming in at $1.82 per share, 31 ...
-
July 26, 2012
Watson Pharmaceuticals Inc.'s (WPI) second quarter 2012 earnings (excluding special items) of $1.42 per share ...
-
July 26, 2012
Pfizer (NYSE:PFE) will release its second quarter results on Tuesday, July 31, 2012. Analysts are expecting earnings ...
-
July 25, 2012
Eli Lilly & Company (LLY) reported second quarter 2012 adjusted earnings per share of 83 cents, 6 cents above the ...
-
July 24, 2012
Pfizer, Inc. (PFE) recently announced highly-awaited top-line results on Alzheimer's disease candidate, ...
-
July 24, 2012
Once upon a time, the conventional wisdom was that investors should hold stocks as a source of long-term capital ...
-
July 23, 2012
Dr. Reddy's Laboratories (RDY) reported first quarter fiscal 2013 earnings per American Depositary Share (ADS) of 40 ...
-
July 23, 2012
Biopharmaceutical giant Bristol-Myers Squibb Company (BMY) is all set to unveil its second quarter 2012 results ...
-
July 23, 2012
New York, July 23rd (TradersHuddle.com) - Shares of Pfizer, Inc. (NYSE:PFE) closed the trading
day lower by $0.1 ...
-
July 20, 2012
Pfizer Inc. (PFE) recently received good news with the United States District Court for the District of Delaware ...
-
July 19, 2012
Yet another generic version of Pfizer's (PFE) cholesterol drug, Lipitor (atorvastatin calcium), entered the market ...
-
July 19, 2012
New York, July 18th (TradersHuddle.com) - Shares of Pfizer, Inc. (NYSE:PFE) closed the session at $23.62 just above ...
-
July 18, 2012
AstraZeneca PLC's (AZN) global biologics division, MedImmune, is set to streamline its infectious disease and ...
